JENNIFER BROWN: Open Payments
NPI 1285625277 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,664 in 97 payments from 21 companies in 2025. Trend: 2023 $1,174 · 2024 $1,387 · 2025 $1,664
Food & beverage: $1,664
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $232 |
| ABBVIE INC. | 14 | $195 |
| Lilly USA, LLC | 9 | $194 |
| PFIZER INC. | 19 | $193 |
| Novo Nordisk Inc | 11 | $164 |
| Axsome Therapeutics, Inc. | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $84 |
| Abbott Laboratories | 4 | $81 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
Products named: FARXIGA, MOUNJARO, Ozempic, JARDIANCE, NURTEC ODT, UBRELVY, FREESTYLE LIBRE 3, Auvelity.
Industry payments across KS — which companies pay providers there.
